FUMAGALLI, CARLO
 Distribuzione geografica
Continente #
EU - Europa 143
AS - Asia 111
NA - Nord America 82
Totale 336
Nazione #
IT - Italia 81
US - Stati Uniti d'America 80
SG - Singapore 58
KR - Corea 38
DE - Germania 27
CN - Cina 11
FI - Finlandia 10
IE - Irlanda 7
FR - Francia 3
GB - Regno Unito 3
NL - Olanda 3
AT - Austria 2
DK - Danimarca 2
CA - Canada 1
ES - Italia 1
IN - India 1
KH - Cambogia 1
LU - Lussemburgo 1
NO - Norvegia 1
PA - Panama 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
TW - Taiwan 1
Totale 336
Città #
Santa Clara 54
Seoul 38
Singapore 28
Naples 21
Munich 18
Caserta 7
Dublin 7
Helsinki 6
Milan 6
Angri 4
Lappeenranta 4
Nuremberg 4
Trentola-Ducenta 4
Verona 4
Florence 3
Salerno 3
Torre del Greco 3
Camden 2
Kronberg 2
San Nicola la Strada 2
Ashburn 1
Aversa 1
Boardman 1
Bratislava 1
Bremen 1
Council Bluffs 1
Delft 1
Hyderabad 1
Istanbul 1
Juelsminde 1
Los Angeles 1
Luxembourg 1
Macerata Campania 1
Maddaloni 1
Madrid 1
Orta di Atella 1
Oslo 1
Padova 1
Palena 1
Phnom Penh 1
Pomigliano d'Arco 1
Shanghai 1
Southern Pines 1
Spokane 1
Taipei 1
Washington 1
Totale 246
Nome #
SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes 29
Impact of pregnancy on the natural history of women with hypertrophic cardiomyopathy 16
Low incidence of arrhythmic syncope and pacemaker implantation in older patients with bifascicular block and implantable cardiac monitor 16
Post-procedural fever after transcatheter aortic valve implantation: a retrospective single-centre study 15
Determinants of health status in older patients with transthyretin cardiac amyloidosis: a prospective cohort study 15
GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes 15
Comprehensive Geriatric Assessment to Optimize the Management of Older Patients With Transthyretin Cardiac Amyloidosis 10
From Atrial Fibrillation Management to Atrial Myopathy Assessment: The Evolving Concept of Left Atrium Disease in Hypertrophic Cardiomyopathy 10
Association of Obesity with Adverse Long-Term Outcomes in Hypertrophic Cardiomyopathy 9
Incidence and risk factors for pacemaker implantation in light-chain and transthyretin cardiac amyloidosis 9
Predicting Mortality Risk in Older Hospitalized Persons With COVID-19: A Comparison of the COVID-19 Mortality Risk Score with Frailty and Disability 9
Prevalence of Inherited Cardiac Diseases Among Young Patients Requiring Permanent Pacing 9
Development of an Italian version of the Leicester cough questionnaire and its relationship with other symptom-specific measures for patients with chronic cough 9
Myocardial blood flow in patients with hypertrophic cardiomyopathy receiving perindopril (CARAPaCE): A pilot study 9
Atrial fibrillation and COVID-19 in older patients: how disability contributes to shape the risk profile. An analysis of the GeroCovid registry 9
International patient preferences for physician attire: results from cross-sectional studies in four countries across three continents 8
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 8
Clinical profile of trazodone users in a multisetting older population: data from the Italian GeroCovid Observational study 8
Frailty and caregiver relationship quality in older patients diagnosed with transthyretin cardiac amyloidosis 8
Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study 8
Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis 7
Prognostic Value of a 6-Minute Walk Test in Patients With Transthyretin Cardiac Amyloidosis 7
Clinical presentation and prognosis of COVID-19 in older adults with hypothyroidism: data from the GeroCovid observational study 7
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy 6
Targeted Medical Therapies for Hypertrophic Cardiomyopathy 6
Somatically evoked cough responses help to identify patients with difficult-to-treat chronic cough: a six-month observational cohort study 6
Clinical risk score to predict in-hospital mortality in COVID-19 patients: a retrospective cohort study 6
Incidence and determinants of atrial fibrillation in patients with wild-type transthyretin cardiac amyloidosis 6
Real-World Use and Predictors of Response to Disopyramide in Patients with Obstructive Hypertrophic Cardiomyopathy 6
Layman electrocardiographic screening using smartphone-based multiple‑lead ECG device in school children 6
Age-dependent diagnostic yield of echocardiography as a second-line diagnostic investigation in athletes with abnormalities at preparticipation screening 6
Anticoagulation in atrial fibrillation. A large real-world update 5
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring 5
Relationship between hyponatremia at hospital admission and cardiopulmonary profile at follow-up in patients with SARS-CoV-2 (COVID-19) infection 5
Heart failure with preserved ejection fraction in elderly. From pathophysiology to treatment: An unresolved problem 5
Validation of a multiple‑lead smartphone-based electrocardiograph with automated lead placement for layman use in patients with hypertrophic cardiomyopathy 5
Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with hypertrophic cardiomyopathy 5
Clinical profile and outcome of cardiomyopathies in infants and children seen at a tertiary centre 5
β-blockers: Their new life from hypertension to cancer and migraine 5
Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic Cardiomyopathy: Insights From the SHARE Registry 5
Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy: An Analysis of the International Sarcomeric Human Cardiomyopathy Registry 5
Long-Term Prevalence of Systolic Dysfunction in MYBPC3 Versus MYH7-Related Hypertrophic Cardiomyopathy 5
Low QRS Voltages in Cardiac Amyloidosis: Clinical Correlates and Prognostic Value 4
Lifetime Clinical Course of Hypertrophic Cardiomyopathy: Outcome of the Historical Florence Cohort Over 5 Decades 4
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy 4
Prevalence and predictors of bradyarrhythmias requiring permanent pacing in patients with Anderson–Fabry disease 4
Sex-related differences in exercise performance and outcome of patients with hypertrophic cardiomyopathy 4
Selection and Application of Tissue microRNAs for Nonendoscopic Diagnosis of Barrett's Esophagus 4
Optimal timing of follow-up cardiac magnetic resonance in patients with uncomplicated acute myocarditis 3
Is Metformin Use Associated with a More Favorable COVID-19 Course in People with Diabetes? 3
MitraClip implantation in real-world: clinical relevance of different patterns of left ventricular remodeling 3
Overweight and aging increase the risk of atrial fibrillation after cardiac surgery independently of left atrial size and left ventricular ejection fraction 3
Use of Smartphone-operated ECG for home ECG surveillance in COVID-19 patients 2
Totale 391
Categoria #
all - tutte 3.708
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.708


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202312 0 0 0 0 2 0 0 0 9 0 1 0
2023/2024154 0 0 5 4 4 1 1 30 9 15 33 52
2024/2025225 5 45 13 62 100 0 0 0 0 0 0 0
Totale 391